Skip to content
healthcare.dev

Kisunla

NDC 0002-9401, donanemab-azbt, injection, solution, from Eli Lilly and Company.

Product NDC
0002-9401
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761248
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-9401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DONANEMAB17.5 mg/mL
Package NDCNDC-11Package
0002-9401-01000029401011 VIAL, SINGLE-DOSE in 1 CARTON (0002-9401-01) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/190352d4-ef62-4679-b4fa-e846e2766afa
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0002-9401

Use it

Look up 0002-9401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-9401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-9401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.